PMID- 15756704
OWN - NLM
STAT- MEDLINE
DCOM- 20050802
LR  - 20191114
IS  - 0887-8013 (Print)
IS  - 1098-2825 (Electronic)
IS  - 0887-8013 (Linking)
VI  - 19
IP  - 2
DP  - 2005
TI  - Relationship between renal anemia and prognostic stages of IgA nephropathy.
PG  - 80-3
AB  - In 2002, the Joint Committee of the Special Study Group on Progressive Glomerular 
      Diseases, Ministry of Health, Labor and Welfare of Japan newly revised the 
      clinical guidelines for IgA nephropathy (Sakai et al.: Jpn J Nephrol 37:417-421, 
      1995; Tomino and Sakai: Clin Exp Nephrol, 7, 93-97, 2003). The prognostic stages 
      were classified into four groups: the good prognosis group (Group I), relatively 
      good prognosis group (Group II), relatively poor prognosis group (Group III), and 
      poor prognosis group (Group IV). The relationship between the levels of Hb, Ht, 
      and RBC in peripheral blood and the renal prognostic stages was determined in 62 
      patients with IgA nephropathy in the present study. The mean levels of Hb, Ht, 
      and RBC were significantly lower in Group IV than in Group I (P<0.05). However, 
      there were no significant changes in the levels of serum creatinine (s-Cr) or 
      creatinine clearance (CCr) among these four groups. It appears that the levels of 
      Hb, Ht, and RBC in peripheral blood may be important clinical parameters for the 
      evaluation of prognostic stages in patients with IgA nephropathy.
FAU - Aruga, Seiki
AU  - Aruga S
AD  - Division of Nephrology, Department of Internal Medicine, Juntendo University 
      School of Medicine, Tokyo, Japan.
FAU - Horiuchi, Tomohide
AU  - Horiuchi T
FAU - Shou, Ichiyu
AU  - Shou I
FAU - Tashiro, Kyouichi
AU  - Tashiro K
FAU - Kurusu, Atsushi
AU  - Kurusu A
FAU - Fukui, Mitsumine
AU  - Fukui M
FAU - Horikoshi, Satoshi
AU  - Horikoshi S
FAU - Tomino, Yasuhiko
AU  - Tomino Y
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Clin Lab Anal
JT  - Journal of clinical laboratory analysis
JID - 8801384
RN  - 0 (Hemoglobins)
RN  - 11096-26-7 (Erythropoietin)
RN  - AYI8EX34EU (Creatinine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Anemia/*complications
MH  - Creatinine/blood
MH  - Erythrocyte Count
MH  - Erythropoietin/blood
MH  - Female
MH  - Glomerulonephritis, IGA/complications/*diagnosis
MH  - Hematocrit
MH  - Hemoglobins/analysis
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prognosis
PMC - PMC6807749
EDAT- 2005/03/10 09:00
MHDA- 2005/08/03 09:00
PMCR- 2005/03/08
CRDT- 2005/03/10 09:00
PHST- 2005/03/10 09:00 [pubmed]
PHST- 2005/08/03 09:00 [medline]
PHST- 2005/03/10 09:00 [entrez]
PHST- 2005/03/08 00:00 [pmc-release]
AID - JCLA20056 [pii]
AID - 10.1002/jcla.20056 [doi]
PST - ppublish
SO  - J Clin Lab Anal. 2005;19(2):80-3. doi: 10.1002/jcla.20056.